Parthenotes as a source of embryonic stem cells

Cell Proliferation
Tiziana A L Brevini, Fulvio Gandolfi

Abstract

The derivation and study of human embryonic stem cell lines, despite their potential therapeutic usefulness, raise considerable ethical, religious, legal and political concerns because it inevitably leads to the destruction of viable embryos. In an attempt to bridge the division between ethical questions and potential scientific and medical benefits, considerable efforts have been devoted to the search for alternative sources of pluripotent cell lines. In this review we discuss the use of artificial parthenogenesis as a way to create entities, called parthenotes, that may represent an alternative ethical source for pluripotent cell lines. We describe the biological differences between parthenotes and embryos, in order to provide a rationale for the discussion on whether their use can be acceptable as a source of stem cells. We present data derived from animal models on the extent parthenogenetic stem cells are similar to biparental cell lines and discuss these aspects in the context of their extension to the human species. Finally, we present experiments recently carried out in our laboratory that allowed us to generate human parthenotes through artificial activation of human oocytes and to use them as a source for the derivati...Continue Reading

References

Apr 1, 1992·Molecular Reproduction and Development·C C Henery, M H Kaufman
Nov 1, 1988·Human Reproduction·S J PickeringE Houliston
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R Martin
Mar 1, 1994·Nature Genetics·M S Bartolomei
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A NagyJ C Roder
Nov 1, 1996·Journal of Assisted Reproduction and Genetics·A Rhoton-VlasakD G Hammitt
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·F A Brook, R L Gardner
Nov 6, 1998·Science·J A ThomsonJ M Jones
Mar 29, 2001·Zygote : the Biology of Gametes and Early Embryos·K NakagawaT Aono
Jun 23, 2001·Biology of Reproduction·S M MitalipovD P Wolf
Nov 1, 2001·Annual Review of Cell and Developmental Biology·A G Smith
Feb 2, 2002·Science·Jose B CibelliMichael D West
Apr 23, 2002·Biology of Reproduction·Andrew C BoquestMark B Nottle
Sep 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kent E VranaJose B Cibelli
Oct 17, 2003·Biology of Reproduction·Irina LagutinaCesare Galli
Jul 14, 2004·Gynecologic and Obstetric Investigation·Kazuo SengokuMutsuo Ishikawa
Aug 31, 2004·Reproductive Biomedicine Online·Giuseppe Benagiano, Luca Gianaroli
Dec 8, 2004·Reproduction : the Official Journal of the Society for the Study of Fertility·N T RogersK Swann
Mar 11, 2005·Nature·Ann A Kiessling
Sep 30, 2005·Cytogenetic and Genome Research·A KulievY Verlinsky
Mar 15, 2006·European Journal of Medical Genetics·Franck PellestorSamir Hamamah
Jun 24, 2006·Fertility and Sterility·M Cristina MagliLuca Gianaroli
Aug 25, 2006·Nature·Irina KlimanskayaRobert Lanza
Sep 23, 2006·Stem Cells·Xin ZhangMiodrag Stojkovic
Oct 14, 2006·Stem Cells·Shufen WangWeizhi Ji
Oct 24, 2006·Theriogenology·Tiziana A L BreviniFulvio Gandolfi

❮ Previous
Next ❯

Citations

May 11, 2013·Animal Reproduction Science·Xiaolei HanZhanjun Li
Feb 26, 2013·The Journal of Clinical Investigation·Michael DidiéWolfram-Hubertus Zimmermann
Jun 12, 2010·PloS One·Sohyun L McElroyRenee A Reijo Pera
Dec 20, 2012·PloS One·Carmen Naturil-AlfonsoFrancisco Marco-Jiménez
May 20, 2014·Current Treatment Options in Cardiovascular Medicine·Scott D LundyMichael A Laflamme
Dec 5, 2015·Stem Cells International·Adriana Bos-MikichFlávio V Meirelles
Feb 24, 2010·Nature Reviews. Cardiology·Kai C Wollert, Helmut Drexler
Sep 2, 2016·Reproduction : the Official Journal of the Society for the Study of Fertility·Xiaoxiao HouZiyi Li
Oct 17, 2018·Cellular Reprogramming·Hui ChengBo Tang
Sep 27, 2013·Acta haematologica Polonica·Mariusz Z Ratajczak, Malwina Suszyńska
May 11, 2012·Molecular Reproduction and Development·Julien MaruottiAlice Jouneau
Sep 23, 2014·Molecular Medicine Reports·Jin LiGuangxiu Lu
Jun 27, 2013·Journal of Tissue Engineering and Regenerative Medicine·M MuñozE Gómez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.